Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

9 results
Display

Electroconvulsive Therapy in One Female with Very Early Onset Schizophrenia: A Case Report

Koo JW, Lee MS, Kim SH

  • KMID: 2286806
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):416-420.
Very early-onset schizophrenia (VEOS) has a very rare prevalence, below 2 in one million children. Electroconvulsive therapy (ECT) is a controversial treatment modality that is only rarely performed on children...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Characteristics and Treatments of Major Depressive Disorder with Psychotic Features

Ko YH, Kim SH

  • KMID: 2286798
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):341-350.
Major depressive disorder with psychotic features is fairly common but difficult to be diagnosed and managed. The patients with psychotic depression have psychomotor impairments, guilt, suicidal ideation or attempt, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacological Treatment for Nicotine Dependence

Joe KH, Kim DJ

  • KMID: 2286800
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):361-373.
It was not above two or three decades from the changes began that regarding nicotine dependence as a kind of addictive disorder and a therapeutic target. Despite the short period...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Tryptophan Hydroxylase A218C Polymorphism in Patients with Bipolar Disorder

Kim WT, Kim SK

  • KMID: 2286805
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):406-415.
OBJECTIVE: This study has been carried out to explore the genetic causes of bipolar disorder by comparing the frequency of Tryptophan Hydroxylase (TPH) A218C polymorphism between bipolar disorder patients and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neurobiological Mechanism of Nicotine Dependence

Yoon SJ, Kim DJ

  • KMID: 2286799
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):351-360.
Nicotine, the primary psychoactive components of tobacco smoke, produce diverse neurophysiological and behavioral effects through several brain regions and neurochemical pathways. It acts as an agonist to activate and desensitize...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Cost-Effectiveness between Before and After Risperidone in Schizophrenic Patients

Lee ML, Lee SI, Kim CY, Park JI

  • KMID: 2286802
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):383-389.
OBJECTIVES: This study was intended to compare cost-effectiveness between before and after risperidone in schizophrenic patients. METHODS: Twenty-four patients who have been prescribed traditional antipsychotics, and elapsed at least one...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in Glucose, Lipid Levels and Body Weight in Patients with Schizophrenia Treated with Atypical Antipsychotics

Lee MH, Kim CE, Kang MH, Lee JS, Bae JN

  • KMID: 2286801
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):374-382.
OBJECTIVE: The purpose of this study is to assess the effect of risperidone, olanzapine, quetiapine, amisulpride on glucose, lipid levels and body weight changes in Korean patients with schizophrenia during...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Polypharmacy in Schizophrenic Inpatients: The Comparison between 1997 and 2003 in One University Hospital

Kim W, Bahk WM, Woo YS, Seo HJ, Jun TY, Kim KS, Chae JH

  • KMID: 2286803
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):390-395.
OBJECTIVE: Up to recently, the standard pharmacotherapy of schizophrenia has been monotherapy, use of one antipsychotic medication. However, polypharmacy in patients with schizophrenia is a common practice with little basis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Feasibility of Korean Medication Algorithm for Bipolar Disorder(IV): Quality of Life

Min KJ, Bahk WM, Jon DI, Shin YC, Kim CH, Yoon BH, Cho HS, Kwon JS, Feasibility of Korean Medication Algorithm for Bipolar Disorder Project Group

  • KMID: 2286804
  • Korean J Psychopharmacol.
  • 2005 Sep;16(5):396-405.
OBJECTIVE: The Korean College of Neuropsychopharmacology and the Korean Academy of Schizophrenia developed the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) as a reference for clinical decisions. The purpose...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr